Fall 2011 Volume 30 Number 3 JU LE S STE I N E Y E I N S T I TUTE UCLA

First Page		Document Content
Date: 2011-10-21 13:38:32 University of California Los Angeles Research to Prevent Blindness Jules Stein Eye Institute David Geffen School of Medicine at UCLA Cytomegalovirus retinitis Uveitis Jules C. Stein Casey Wasserman Stem cell treatments Medicine Health Ophthalmology		Fall 2011 Volume 30 Number 3 JU LE S STE I N E Y E I N S T I TUTE UCLA Add to Reading List Source URL: jsei.org Download Document from Source Website File Size: 2,41 MB Share Document on Facebook

	Research Letters AIDS 2005, 19:529–533 Virtual screening of HIV-1 protease inhibitors against human cytomegalovirus protease using docking and molecular dynamics DocID: 1gdqP - View Document
	AIDS Research and Therapy BioMed Central Open Access DocID: 1602b - View Document
	VALGANCICLOVIR ChAMP Monographs DESCRIPTION ChAMP INDICATIONS AND DocID: 11hkH - View Document
	Lions Eye Institute Honours Projects[removed]Research Groups Experimental Immunology 1. Viruses and Autoimmune Disease in the Eye DocID: 10DiK - View Document
	VALCYTE(R) Tablets Pronounced VAL-SITE contains the active ingredient valganciclovir Consumer Medicine Information DocID: Y5Wm - View Document